U.S. Sterilization Services Market Size, Share, Trends, Industry Analysis Report: By Service (Contract Sterilization Services and Validation Sterilization Services) and Delivery Mode

Description

List of Tables

The U.S. Sterilization Services market size is expected to reach USD 4,176.46 Million by 2034, according to a new study by Polaris Market Research. The report "U.S. Sterilization Services Market Size, Share, Trends, Industry Analysis Report: By Service (Contract Sterilization Services and Validation Sterilization Services) and Delivery Mode - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. Sterilization Services Market encompasses the provision of specialized processes designed to eliminate all viable forms of microbial life, including bacteria, viruses, fungi, and bacterial spores, from medical devices, pharmaceutical preparations, and other healthcare-related products. These critical services are essential for ensuring patient safety by preventing the transmission of infections within healthcare environments. The market caters to a diverse clientele, including hospitals, ambulatory surgical centers, medical device manufacturers, and pharmaceutical companies, all of whom require assurance that their products meet stringent sterility standards mandated by regulatory authorities.

The U.S. Sterilization Services Market is a significant and evolving sector within the healthcare industry. Its growth is propelled by increasing awareness of healthcare-associated infections (HAIs), stringent regulatory requirements imposed by agencies like the FDA, and the rising volume of surgical procedures and medical device utilization. The market comprises various service segments, including contract sterilization, where organizations outsource their sterilization needs, and validation services, which focus on verifying the efficacy of sterilization processes. Key market dynamics include a growing trend towards outsourcing, technological advancements in sterilization methods, and a heightened focus on sustainable practices. The market outlook remains positive, driven by continuous market demand for reliable and compliant sterilization solutions.

U.S. Sterilization Services Market Report Highlights:

By service, the U.S. Sterilization Services Market is segmented by service into contract sterilization services and validation sterilization services. Among these service types, contract sterilization services currently holds the largest portion of the overall market share.

By delivery mode, the U.S. Sterilization Services Market is segmented by delivery mode into offsite and onsite. Currently, the offsite delivery mode accounts for the largest market share.

Some names of major active players in the U.S. Sterilization Services market include STERIS Corporation, Cantel Medical (now part of STERIS Corporation, but mentioning separately as per the instruction to list active players), Getinge AB, Advanced Sterilization Products (a Fortive company), Medivators Inc. (also part of Cantel Medical/STERIS), 3M Company, Cardinal Health, Olympus Corporation, Belimed Infection Control (Metall Zug AG), Wipak Medical, Noxilizer, Inc., and Tuttnauer USA Co.

Polaris Market Research has segmented the U.S. Sterilization Services market report based on service and delivery mode:

By Service Outlook (Revenue-USD Million, 2020-2034)

Contract Sterilization Services

Validation Sterilization Services

By Delivery Mode Outlook (Revenue-USD Million, 2020-2034)

Offsite

Onsite

Product Code: PM5644

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. U.S. Sterilization Services Market Insights

4.1. U.S. Sterilization Services Market - Market Snapshot
4.2. U.S. Sterilization Services Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Heightened Focus on Infection Prevention and Control
  - 4.2.1.2. Strict Regulatory Framework and Compliance Mandates
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory and Environmental Concerns
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Sterilization Services Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. U.S. Sterilization Services Market, by Service

5.1. Key Findings
5.2. Introduction
- 5.2.1. U.S. Sterilization Services Market, by Service, 2020-2034 (USD Million)
5.3. Contract Sterilization Services
- 5.3.1. U.S. Sterilization Services Market, by Contract Sterilization Services, by Region, 2020-2034 (USD Million)
5.4. Validation Sterilization Services
- 5.4.1. U.S. Sterilization Services Market, by Validation Sterilization Services, by Region, 2020-2034 (USD Million)

6. U.S. Sterilization Services Market, by Delivery Mode

6.1. Key Findings
6.2. Introduction
- 6.2.1. U.S. Sterilization Services Market, by Delivery Mode, 2020-2034 (USD Million)
6.3. Offsite
- 6.3.1. U.S. Sterilization Services Market, by Offsite, by Region, 2020-2034 (USD Million)
6.4. Onsite
- 6.4.1. U.S. Sterilization Services Market, by Onsite, by Region, 2020-2034 (USD Million)

7. Competitive Landscape

7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

8.1. 3M Company
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Recent Development
8.2. Advanced Sterilization Products (a Fortive company)
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Recent Development
8.3. Belimed Infection Control (Metall Zug AG)
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Recent Development
8.4. Cantel Medical (now part of STERIS Corporation)
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Recent Development
8.5. Cardinal Health
- 8.5.1. Company Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Recent Development
8.6. Getinge AB
- 8.6.1. Company Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Recent Development
8.7. Medivators Inc. (also part of Cantel Medical/STERIS)
- 8.7.1. Company Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Recent Development
8.8. Noxilizer, Inc.
- 8.8.1. Company Overview
- 8.8.2. Financial Performance
- 8.8.3. Product Benchmarking
- 8.8.4. Recent Development
8.9. Olympus Corporation
- 8.9.1. Company Overview
- 8.9.2. Financial Performance
- 8.9.3. Product Benchmarking
- 8.9.4. Recent Development
8.10. STERIS Corporation
- 8.10.1. Company Overview
- 8.10.2. Financial Performance
- 8.10.3. Product Benchmarking
- 8.10.4. Recent Development
8.11. Tuttnauer USA Co.
- 8.11.1. Company Overview
- 8.11.2. Financial Performance
- 8.11.3. Product Benchmarking
- 8.11.4. Recent Development
8.12. Wipak Medical
- 8.12.1. Company Overview
- 8.12.2. Financial Performance
- 8.12.3. Product Benchmarking
- 8.12.4. Recent Development